Health Care | Pharmaceuticals, Biotechnology & Life Sciences | Biotechnology
NASDAQ | Common Stock
Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers.
The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors.
It also develops HSB-3215, an anti-HER2 monoclonal antibody candidate; and HSB-1940, a Quatrabody that is a proprietary IO biologic in development targeting PD-1.
The company was incorporated in 2017 and is based in Bridgewater, New Jersey.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 28, 24 | 0.00 Increased by +100.00% | -0.04 Increased by +100.00% |
| Nov 29, 23 | 0.00 Increased by +100.00% | -0.05 Increased by +100.00% |
| Aug 11, 23 | -0.16 Decreased by -14.29% | -0.16 |
| May 22, 23 | -0.23 Decreased by -204.55% | -0.11 Decreased by -109.09% |
| Mar 16, 23 | -0.15 Decreased by -91.75% | - |
| Nov 14, 22 | -0.18 Increased by +50.14% | - |
| Aug 10, 22 | -0.14 Increased by +42.81% | - |
| Apr 1, 22 | 0.22 Increased by +162.16% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 0.00 Decreased by N/A% | -1.82 M Increased by +14.45% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -2.34 M Decreased by -42.77% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -2.67 M Decreased by -208.78% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -1.60 B Decreased by -65.17 K% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -2.13 M Decreased by -149.28% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by N/A% | -1.64 M Decreased by -5.19% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 Decreased by N/A% | 2.45 M Increased by +209.02% | Increased by +N/A% Decreased by N/A% |
| Dec 31, 21 | 0.00 Decreased by N/A% | 2.45 M Increased by +289.29% | Increased by +N/A% Decreased by N/A% |